The 2026 review is blunt that diet is secondary, noting these measures are substantially less effective if dose titration is not actively and thoughtfully managed
Clinical Eligibility Framework: Who Benefits Most Determining who should start GLP-1 therapy involves assessing weight status, comorbidities, metabolic biomarkers, and personal health goals
Quick Answer: Whilst tirzepatide has no absolute food contraindications, patients should avoid high-fat foods, ultra-processed items, refined sugars, and excessive alcohol to minimise gastrointestinal side effects and optimise treatment outcomes
Measurable changes in lean mass and body fat typically emerge around weeks 816
A review of the SURPASS-3 and SURPASS-4 trials, which followed participants for up to two years, showed that some people reported: Generalized muscle soreness Joint pain, particularly in the legs and back Increased muscle fatigue However, these symptoms were not as widely reported as nausea or digestive problems
Melanoma is the deadliest form of skin cancer, sending about 8,000 Americans to the grave each year At present, there are no studies on the long-term safety or efficacy of Melanotan II use